Diagnostic options · UAE

Oncogenetics tests in Dubai & UAE

Compare available Oncogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Oncogenetics test prices

Showing 1–6 of 6 matching tests.

Oncogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1970 CDKN2B / MEN1 Genetic Screening (Multiple Endocrine Neoplasia Type 1) Test This genetic test identifies pathogenic variants in the CDKN2B and MEN1 genes associated with Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome and related conditions.	Whole blood (EDTA) or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CDKN2B gene", "Pathogenic variants in MEN1 gene", "Copy Number Variations (CNV) in CDKN2B and MEN1 genes"] Parameters [] Preparation ["No fasting required.", "Compulsory genetic counselling session prior to testing.", "Provide full clinical history and family pedigree.", "Ensure FTA card samples are kept dry and away from direct heat."] Indications ["Individuals with clinical features suggestive of MEN1 syndrome.", "Individuals with a first-degree relative diagnosed with MEN1 syndrome.", "Individuals with a family history of pancreatic neuroendocrine tumors or familial atypical multiple mole melanoma.", "Pre-symptomatic screening in high-risk families."] Measurement technique Confirm with laboratory Codes LOINC: 94046-2 ICD-10: E31.2 Clinical summary This genetic test identifies pathogenic variants in the CDKN2B and MEN1 genes associated with Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome and related conditions.
TEST-1953 Familial Pancreatic Cancer‑Melanoma Syndrome (CDKN2A Gene) NGS Test This test evaluates the entire coding region and intron-exon boundaries of the CDKN2A gene for germline mutations associated with increased risk of pancreatic cancer and melanoma.	Peripheral whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN2A gene mutations", "Copy number variants (CNVs) in CDKN2A", "Lifetime risk stratification for pancreatic cancer and melanoma"] Parameters [] Preparation [] Indications ["Individuals with a strong family history of pancreatic cancer, melanoma, or multiple primary malignancies.", "Individuals seeking definitive hereditary risk stratification for these cancers."] Measurement technique Confirm with laboratory Codes LOINC: 94222-0 ICD-10: Z15.09 Clinical summary This test evaluates the entire coding region and intron-exon boundaries of the CDKN2A gene for germline mutations associated with increased risk of pancreatic cancer and melanoma.
TEST-1897 MET Gene (Hereditary Papillary Renal Cell Carcinoma Type 1) Genetic Test This genetic test evaluates the MET gene for germline mutations associated with an increased risk of hereditary papillary renal cell carcinoma type 1.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MET gene coding region", "Germline mutations (SNVs, deletions, CNVs)"] Parameters [] Preparation [] Indications ["Individuals with a family history suggestive of HPRCC", "First-degree relatives of known MET mutation carriers", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21626-7 ICD-10: C64.9, Z80.5 Clinical summary This genetic test evaluates the MET gene for germline mutations associated with an increased risk of hereditary papillary renal cell carcinoma type 1.
TEST-1239 PDGFRβ (CMML) Gene Rearrangement Test This diagnostic test evaluates for rearrangements in the PDGFRβ gene, a key marker for Chronic Myelomonocytic Leukemia (CMML).	Bone Marrow Aspirate or Peripheral Blood (EDTA)	3–4 days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PDGFRβ gene rearrangement", "Chromosome 5q32-33 alterations"] Parameters [] Preparation ["Fasting is not required.", "No specific medication or diet restrictions."] Indications ["Diagnosis of Chronic Myelomonocytic Leukemia (CMML)", "Prognosis assessment in CMML", "Prediction of response to tyrosine kinase inhibitors (e.g., imatinib)"] Measurement technique Confirm with laboratory Codes LOINC: 92847-3 ICD-10: C93.1 Clinical summary This diagnostic test evaluates for rearrangements in the PDGFRβ gene, a key marker for Chronic Myelomonocytic Leukemia (CMML).
TEST-2083 PIK3CA Gene Cowden Syndrome Type 5 Genetic Test This test detects pathogenic variants in the PIK3CA gene associated with Cowden syndrome type 5, a hereditary cancer predisposition syndrome.	Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIK3CA gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)"] Parameters [{"name": "PIK3CA Gene Variants", "reference_range": "Negative for pathogenic/likely pathogenic variants"}] Preparation ["Mandatory pre-test genetic counselling session", "Inform counsellor of recent blood transfusions or pregnancy"] Indications ["Individuals with a personal or family history suggestive of Cowden syndrome", "Confirmation of clinical diagnosis", "Risk assessment for hereditary cancer predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 94074-4 ICD-10: Q85.81, Z15.01, Z15.09 Clinical summary This test detects pathogenic variants in the PIK3CA gene associated with Cowden syndrome type 5, a hereditary cancer predisposition syndrome.
TEST-1961 PRKAR1A Gene Myxoma, Intracardiac Genetic Test This test detects pathogenic variants in the PRKAR1A gene associated with Carney complex and intracardiac myxoma.	Whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKAR1A gene", "Single-nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation [] Indications ["Clinical suspicion of Carney complex", "Intracardiac myxoma", "Family history of Carney complex or myxoma"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D15.1 Clinical summary This test detects pathogenic variants in the PRKAR1A gene associated with Carney complex and intracardiac myxoma.

Category overview

Oncogenetics: overview

Understanding your inherited cancer risks can feel overwhelming, but securing a clear molecular profile empowers you to protect your future. Housed within our Molecular Diagnostics division, our Oncogenetics testing utilizes state-of-the-art DNA sequencing to thoroughly evaluate hereditary markers linked to various cancers. This comprehensive oncogenetics data acts as a powerful foundational tool for your physician, delivering the exact insights required for tailored, preventive medical guidance rather than a definitive standalone diagnosis. Recognized among the most respected diagnostic labs in the UAE, DNA Labs UAE prioritizes absolute patient confidentiality and consistently rapid, highly accurate results. Step confidently into proactive wellness: explore our oncogenetics testing in the UAE below to book an appointment, schedule a seamless home sample collection, or contact our dedicated medical experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.